ReShape Lifesciences Announces First Quarter 2019 Financial Results

Author's Avatar
May 20, 2019
Article's Main Image

SAN CLEMENTE, CA / ACCESSWIRE / May 20, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today reported financial results for the three months ended March 31, 2019.